Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-033296

General Counsel sold 30,000 shares at $24.88 ($746,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Brien Patrick General Counsel 2019-05-28 Sale −30,000 $24.88 $746,400 203,000 D
Open-market sales · 30,000 sh · avg $24.88 · $746,400
Loading xslF345X03/doc4.xml…